Schizophrenia Clinical Trial
Official title:
Implementation of Illness Management and Recovery in Mental Health Services: Facilitators and Barriers in the Implementation Process.
The purpose of this study is to examine the barriers and facilitators of implementing Illness Management and Recovery (IMR) in Norwegian mental health services.
Status | Completed |
Enrollment | 40 |
Est. completion date | June 2015 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria Therapists: - Voluntary recruited therapists in the participating mental health services - trained and consulted in IMR Inclusion Criteria Patients: - Adults (18+) - Associated with one of the participating mental health services - symptoms on or diagnosis of severe mental illness with or without drug abuse - giving informed consent verbally and in writing Exclusion Criteria Patients: - Patients with acute risk of suicidal behaviour - not able to communicate in Norwegian |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Norway | Ahus R&D Mental Health Services | Lørenskog |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Akershus | Helse Sor-Ost, Romeriksprosjektet |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Illness Management Fidelity Scale (SAMHSA, 2009) | Assesses the degree of fidelity with 13 items on a 5-point likert scale where 5 indicates full implementation and 0 indicates no implementation | 12 months | No |
Secondary | The Illness Management & Recovery Treatment Integrity Scale (IT-IS) (McGuire et al., 2012 | A 16-item scale measuring clinicians' faithful replication of the model | 12 months | No |
Secondary | The Adult State Hope Scale (Snyder et al., 1996) | A 6-item self-report scale of patients' hope and optimism | 12 months | No |
Secondary | The Illness Management and Recovery Scale (SAMHSA, 2009) | Assessing patients' recovery outcomes in the IMR program with 15 items. | About 11 months after start of intervention | No |
Secondary | General Organizational Index (SAMHSA, 2009) | A 12-item scale measuring organisational outcome of implementation by common agency practices that support evidence-based practices | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |